Struvite urolithiasis with Corynebacterium urealyticum infection: A case report  by Martín-Navarro, Juan A. et al.
n e f r o l o g i a. 2 0 1 5;3 5(4):410–417
Revista de la Sociedad Española de Nefrología
w w w.rev is tanef ro logia .com
Letters to the Editor – Brief papers about basic research or clinical experiences
Struvite  urolithiasis  with  Corynebacterium  urealyticum
infection: A  case report
Urolitiasis  por  estruvita  en  infección  por  Corynebacterium  urealyticum.
A  propósito  de  un  caso
Juan A. Martín-Navarroa,∗, Vladimir Petkov-Stoyanova,
M.  José Gutiérrez-Sáncheza, M. Esther Gordo-Floresba Unidad de Nefrología, Hospital del Tajo, Aranjuez, Madrid, Spain
and to acquire resistance to multiple antibiotics geneticallyb Servicio de Urología, Hospital del Tajo, Aranjuez, Madrid, Spain
To the Editor,
Struvite urolithiasis is an uncommon clinical scenario, usually
associated with urinary infections caused by urease-positive
organisms and with renal transplant,1 which requires a high
degree of clinical suspicion and microbiological collaboration
for its diagnosis. We  describe the case of a 76-year-old man
with a past medical history of COPD, cor pulmonale, previ-
ous ischaemic stroke, and multiple admissions for respiratory
infections, requiring prolonged antibiotic therapy. He had an
indwelling urinary catheter for prostatic obstructive uropa-
thy, and regular medications were acenocoumarol, inhaled
beta-agonists, furosemide, and dutasteride-tamsulosin. In
the previous 3 months he had had recurrent urinary infec-
tions caused by various bacteria, with an acidic urinary pH,
and had been treated with quinolones and beta-lactams.
He began attending the emergency room repeatedly with
catheter obstruction. Urine was turbid, thick, and milky, with
an ammoniacal odour. Standard urine culture and urine
mycobacteria and fungus culture were repeatedly negative.
Despite changing the catheter, several oral antibiotic regimens
and nightly antibiotic prophylaxis, the problem persisted, with
progressively alkalotic urine and a sediment with magnesium
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on removing the catheter, we observed a petrous material in
the form of orange-brown hexagonal crystals (Figs. 1 and 2)
that was subsequently identiﬁed as struvite. Urine culture was
repeated, and grew a Corynebacterium urealyticum (CU) sensitive
to glycopeptides. It was treated with teicoplanin for 15 days
with good clinical resolution.
CU is a strictly aerobic diphtheriform Gram-positive coc-
cobacillus, and was characterised between 1985 and 1992.2
Initially, it was called coryneform D2. It is a common inhabitant
of skin and mucous membranes, mainly in the perigeni-
tal region of women. It can be isolated from fomites and
in the air of rooms of colonised individuals. It acts as an
opportunistic organism in the urinary tract and infects from
a heavy inoculum and by antibiotic selection, facilitated by
interventions that allow it to penetrate (such as urinary
catheterisation, cystoscopy, surgery, or renal transplant). It
is characterised by having a urease gene with no repres-
sor, the ability to synthesise proteinaceous pili and bioﬁlms,tiérrez-Sánchez MJ, Gordo-Flores ME. Urolitiasis por estruvita en
ologia. 2015;35:410–411.
(macrolides, lincosamides, ketolides, chloramphenicol, tetra-
cycline, streptomycin and other AMGs), and by DNA gyrase
mutations (to beta-lactams and quinolones). It causes cystitis,
vier España, S.L.U. This is an open access article under the CC
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Fig. 1 – Appearance of obstructed urinary catheter.
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ryelonephritis, and encrusted cystitis that in transplants can
esult in encrusted pyelitis and graft loss. Less often, it can
ead to endocarditis, soft tissue infections, and osteomyeli-
is. It does not grow in normal media, therefore a prolonged
ncubation time and use of enriched media are recommended
Blood agar at 35 ◦C, chocolate agar, CLED, MacClonkey agar).
t should be suspected when faced with the clinical pic-
ure of urinary infection with alkaline pH urine, magnesium
mmonium phosphate crystals (struvite) in the sediment, and
Fig. 2 – Struvite crystal.
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recurrent urinary retention. It is usually resistant to beta-
lactams, aminoglycosides and quinolones, and sensitive to
vancomycin and teicoplanin (sensitive in vitro to Synercid®,
linezolid, and glycylcyclines). Treatment requires removal
and de-encrustation of foreign bodies (such as catheters or
cystocopes) and urine should be acidiﬁed, for which aceto-
hydroxamic acid (Uronefrex®), vitamin C, fucidic acid, citric
acid, and bladder irrigation using citric acid with glucono-
delta-lactone and magnesium carbonate (Renacidin®) are all
useful.
In the literature we ﬁnd mainly isolated cases3–6 and a
review of 163 transplant patients1 in which 9.8% of pos-
itive cultures were attributed to CU. The pathogenesis is
explained,7 beginning with a prolonged inﬂammation that
induces stimulation of cytokines and growth factors in the
bladder, with the consequent activation of smooth muscle
cells, endothelial cells, and pericytes that differentiate into
osteoblasts capable of generating bone (calcium, hydroxyap-
atite, and collagen) on stimulation of calciﬁcation regulatory
proteins. The apoptotic remains of the damaged cells act
as crystallisation nuclei and the alkaline pH allows pre-
cipitation of crystals. The mechanism can be blocked with
appropriate antibiotic treatment and accelerated with vita-
min  K inhibitors, as osteocalcin, essential for the calciﬁcation
process, is vitamin K-dependent. Therefore, acenocoumarol
would induce osteocalcin overexpression, representing an
added risk factor.
Our case was contracted due to the presence of a
petrous material, made of hexagonal crystals that repeatedly
obstructed the urinary catheter as can be seen in the ﬁgures.
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